Supplements
boswellia decreases osteoarthritis pain
In plain terms: Does boswellia (frankincense) help arthritis and joint pain?
Part of: 🧪 boswellia
Yes — it's one of the better-proven herbal joint remedies. Multiple trials find standardized boswellia extract eases knee-osteoarthritis pain and stiffness about as well as anti-inflammatory drugs, often with gentler effects on the stomach.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Boswellia's standout claim, and it's well-earned: multiple independent meta-analyses of RCTs find standardized Boswellia serrata extract (often the AKBA-enriched forms Aflapin/5-Loxin) reduces knee-osteoarthritis pain and improves function, with a favourable safety profile versus NSAIDs. One of the better-evidenced herbal joint remedies.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Kimmatkar 2003 · Phytomedicine | RCT | supports | moderate | Landmark RCT: Boswellia serrata extract reduced knee pain and improved function/walking versus placebo. |
| Du P et al 2025 · study_type: meta-analysis | meta-analysis | supports | moderate | Network meta-analysis of 22 RCTs/2777 participants comparing dietary supplements for knee OA via WOMAC; Aflapin (a Boswellia serrata extract) ranked among the most effective interventions specifically for reducing WOMAC pain subscore vs pla |
| Kumar B et al 2025 · study_type: RCT | RCT | supports | moderate | 80 adults with Kellgren-Lawrence II-III knee OA, 180-day RCT of Boswellia serrata extract SN13108F (Aflapin, 100mg/day) vs placebo; WOMAC, VAS and Lequesne scores significantly reduced (p<0.001) and MRI showed increased cartilage volume/thi |
| Majeed 2019 · Phytother Res | RCT | supports | moderate | Double-blind RCT (Boswellin/AKBA): reduced OA pain and improved physical function with good tolerability. ↩ SUPERSEDED — pooled in the review above, counted once |
| d10-12775-qs-2026-56-72067 2026 · Quality in Sport | observational | supports | moderate | Structured narrative review of Boswellia serrata phytochemistry/mechanisms/clinical evidence in OA/RA; reports standardised extracts produce 'clinically meaningful reductions in WOMAC and VAS scores in knee OA,' citing a Cochrane synthesis |
| Zhang 2025 · Nutrients | meta-analysis | supports | moderate | Comparative-effectiveness meta-analysis of knee-OA supplements: Boswellia showed significant symptom benefit. |
| Dalmonte 2024 · Phytother Res | meta-analysis | mixed | moderate | Meta-analysis: Boswellia oleogum-resin extracts significantly reduced pain and improved function in knee osteoarthritis. |
| Dubey 2024 · Explore (NY) | RCT | supports | moderate | RCT (standardized Aflapin extract): improved OA pain and function versus placebo. |
| Inprasit C et al 2026 · study_type: meta-analysis | meta-analysis | mixed | moderate | Systematic review + network meta-analysis, 20 RCTs/1633 participants comparing Curcuma longa (CL) and Boswellia serrata (BS) in knee OA; modified BS formulations showed significant improvement in WOMAC pain, stiffness and function vs compar |
| Bannuru 2018 · Semin Arthritis Rheum | meta-analysis | supports | high | SR+meta-analysis: both curcumin and Boswellia were efficacious for knee-OA pain/function versus placebo. |
| Yu 2020 · BMC Complement Med Ther | meta-analysis | supports | moderate | Systematic review: Boswellia and its extracts improved OA pain, stiffness and function. |
| Liu 2018 · Br J Sports Med | meta-analysis | supports | high | Network meta-analysis (Br J Sports Med): Boswellia was among the dietary supplements effective for OA pain and function. |
| Jayaram M et al 2025 · study_type: RCT | RCT | supports | moderate | 150 adults with non/mild knee OA, randomized double-blind placebo-controlled, Boswellia serrata extract BOSMAX 90 days; WOMAC total decreased significantly vs placebo/baseline (-24.55 at day 90, p<0.05), VAS and Lequesne also improved, TNF- |
| Park D et al 2026 · study_type: observational | observational | supports | moderate | Narrative review (SANRA-informed) of nutraceuticals for knee OA with sarcopenia; across glucosamine/chondroitin, collagen peptides, omega-3, curcumin and Boswellia, symptomatic benefits were 'modest, heterogeneous, and formulation-dependent |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.